Sandra Baos

Sandra is an Analyst at 2048 Ventures.
Prior to 2048 Ventures, Sandra served as the Director of Mentor Relations at Nucleate's New York chapter.
In this role, Sandra coordinated the pairings between network advisors and the first two cohorts of the Activator program in NY, and played an active role in sourcing and evaluating early-stage technologies from academic institutions.
She also worked as a Business Development Intern at New York University, where she contributed to accelerate the path to market of NYU’s life sciences technologies.
Sandra has almost a decade of experience in translational research in immunology and molecular biology.
She holds a B.S.
in Biotechnology from the University of Salamanca, a M.S.
in Immunology from the Complutense University of Madrid, and a Ph.D.
in Molecular Biosciences from the Autonomous University of Madrid.
After completing her Ph.D., she joined the Schneider Lab at NYU as a postdoctoral scientist, where she pioneered research on translational reprogramming of T cells, and helped launch an mRNA binding protein therapeutics company.